The results of carmine staining analyses of 4‐ to 10‐week‐old mice showed a significant reduction in the growth of breast tumors during malignant transition stage in IL‐22−/−/PyMT mice (Fig. 1A). This evidence concerns the gene IL22 and breast neoplasm.